Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Intermediate I. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109096139B discloses a novel metal-free method for preparing alpha-carbonyl amides using water as an oxygen source, offering significant cost and purity advantages for pharmaceutical intermediate manufacturing.
Patent CN113105402B details a metal-free route to 3,4,5-trisubstituted 1,2,4-triazoles, offering significant cost reduction in API manufacturing and scalable production capabilities.
Novel palladium-catalyzed carbonylation method for synthesizing carbonyl-bridged biheterocycles without toxic CO gas, offering safer pharmaceutical intermediate manufacturing.
Novel palladium-catalyzed tandem reaction enables efficient one-step synthesis. Reduces complexity and enhances supply chain reliability for pharmaceutical intermediates.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method yielding high-purity axially chiral oxindole-substituted styrenes for asymmetric catalysis applications.
Novel metal-free route for trifluoromethyl triazines. Reduces cost in API manufacturing with high purity and scalable conditions.
Novel chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-substituted styrenes. High ee values up to 96%. Ideal for pharma intermediates.
Patent CN117417339A details Rhodium-catalyzed synthesis offering high purity and scalable production for global pharmaceutical supply chains.
Patent CN103554023B reveals mild ZnCl2 catalysis for high-yield acridine synthesis, offering cost-effective scalable solutions for pharmaceutical intermediates.
Patent CN112898192B details a novel Pd-catalyzed carbonylation route for N-acyl indoles, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN112694430B reveals a novel Pd-catalyzed bis-carbonylation route for 1,5-dihydro-2H-pyrrole-2-one intermediates, offering high efficiency and substrate compatibility for API manufacturing.
Patent CN112778272B reveals a novel Ir-catalyzed route for 2,2'-biazaaryl ligands, offering significant cost reduction and scalable manufacturing for pharma intermediates.
Patent CN115353511A details a safe, one-pot synthesis of carbonyl-bridged biheterocycles using in-situ CO generation, offering reliable pharmaceutical intermediate supply.
Patent CN112480015B details a safe one-pot synthesis of 2-trifluoromethyl quinazolinones using nitro compounds, offering significant cost reduction and supply chain reliability for API manufacturing.
Patent CN113045489B details a novel Pd-catalyzed aminocarbonylation route for 3-arylquinolin-2(1H)ones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Novel axial chiral bisindole catalysts for asymmetric synthesis. Superior stereoselectivity and mild conditions for pharmaceutical intermediates manufacturing.
Novel four-component one-step synthesis enables high-yield, scalable production of structurally diverse calixarene derivatives with superior recognition properties for industrial applications.
Patent CN118271227A enables scalable, mild synthesis of 4-formylpyrrole derivatives via silver catalysis, offering high yield and simplified purification for pharmaceutical supply chains.
Patent CN119306765B enables high-yield asymmetric synthesis of florfenicol and chloramphenicol intermediates with superior stereoselectivity and scalable catalytic efficiency.
Innovative nickel-catalyzed method eliminates toxic sulfur sources and achieves high functional group tolerance for cost-effective pharmaceutical intermediate production.